GlassScriptPhysician profile
Roshansa Singh
NPI 1144783960
$3,352.32
in general payments reported to CMS, 2019-2025
8 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.14 · 2022: $122 · 2023: $51.31 · 2024: $1,698 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,743 · Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,742.74 |
| Food and Beverage | $1,404.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,846.39 | 2024-2025 | Inspire |
| Stryker Corporation | $590.47 | 2025 | Core, Scopis Ent, Xpress Loprofile |
| Medtronic, INC. | $504.68 | 2021-2025 | Propel, Stealthstation S8 Platform, Straightshot |
| Genzyme Corporation | $192.28 | 2024-2025 | |
| Glaxosmithkline, LLC. | $99.97 | 2025 | Nucala |
| Aerin Medical INC. | $56.35 | 2024-2025 | |
| Smith+Nephew, INC. | $32.03 | 2025 | Halo |
| Regeneron Healthcare Solutions, INC. | $30.15 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshansa Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.